Inderes käyttää evästeitä tarjotakseen paremman käyttökokemuksen ja henkilökohtaisemman palvelun. Hyväksymällä evästeiden käytön voimme kehittää palvelua entistä paremmin ja pystymme tarjoamaan sinua kiinnostavaa sisältöä.
Nolato operates in the manufacturing industry and focuses on the development, manufacture and distribution of plastic components and systems for various industries. The company's products are used in sectors such as the automotive industry, medical technology and consumer electronics. The business is global with a main presence in Europe, North America and Asia. Nolato was founded in 1938 and is headquartered in Torekov, Sweden.
* Medical growth shines; positive margin trajectory ahead * EBITA lowered by 1-% for '26e-'28e, driven by Engineered * Share trading at 12x '27e EV/EBITA (5Y average 15x) Medical growth accelerating, held back by Engineered Nolato delivered a decent ...
* Adj. EBITA SEK 262m (-2% vs. ABG, -3% vs. MFN cons) * Soft org. growth at 3% (ABG 6%), but Medical delivered 9% (ABG 7%) * We expect no material revisions to cons adj. EBITA Q3 outcome Sales came in at SEK 2,500m (-2% vs. ABG 2,543m, -1% vs. Modular...
* Q3e: sequential step-up in organic growth and margin * M&A the main driver behind our EBITA upgrades * Two new acquisitions end the three-year M&A hiatus Q3e: sequential step-up in organic growth and margin For Q3e, we expect Nolato to report net sales...
* Q2 below expectations, largely due to temporary effects * We cut our EBITA estimates by 3% for '26e, 1% for '27e-'28e * Organic growth to accelerate in H2e, and M&A potential on top Miss in Q2 driven mainly by temporary effects Nolato reported Q2 adj...
* Adj. EBITA SEK 253m (-7% vs. ABG, -3% vs. MFN cons) * We expect cons EBITA to come down by 2-3% * Share trading at 13-11x '26e-'27e EV/EBITA Q2 outcome Sales came in at SEK 2,454m (-1% vs. ABG 2,467m, 0% vs. Modular Finance cons 2,453m), up 2% y-o-...
* Q2e: some GLP-1 ramp-up, more to come in H2e * Estimates up on FX and higher growth in Engineered * Trading at 13x '26e EV/EBITA vs. historical average of 15x Q2e: slight organic acceleration, more to come in H2e We expect Nolato to report Q2 net sales...
* Christer Wahlquist stepping down, Anders Björklund new CEO * Pre-planned, internal recruitment should make for a smooth transition * A loss for the company, but still plenty of experience in the mgmt. team Anders Björklund appointed new CEO Nolato ...
* Company confident about parrying input cost pressure * We make only minor estimate revisions * Accelerating organic growth ahead, and room for M&A Company confident about parrying input cost pressure Going into the report, our key concern was related...
* EBITA SEK 260m (-2% vs. ABG, 0% vs. IR consensus) * We expect no material revisions to cons EBITA * Share trading at 13x '26e EV/EBITA on our pre-Q1 estimates Q1 outcome Sales came in at SEK 2,357m (-2% vs. ABG 2,394m, 0% vs. IR cons 2,358m), down ...